Valérie Triassi

Valérie Triassi

Auto-generated profile, based on publicly available information

Valérie Triassi

University of Montréal Hospital Research Center (CRCHUM), Montreal H2X 0A9, Quebec Canada

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2026 in medRxiv
Verified
Preprint
Open access
PDF file
KOKatarzyna Ochenkowska
Katarzyna Ochenkowska
BRBryce Rampal
Bryce Rampal
ALAntoine Légaré
Antoine Légaré
VTValérie Triassi
Valérie Triassi
SASébastien Audet
Sébastien Audet
ESEric Samarut
Eric Samarut
Developmental and epileptic encephalopathies (DEEs) are a group of severe childhood-onset neurological disorders, often caused by rare genetic variants affecting brain development and excitability. Despite advances in genomic sequencing, a substantial proportion of DEE cases remain unsolved. Here, we identify THAP12 as a novel disease-causing gene associated with autosomal recessive DEE. Whole-genome sequencing in two siblings who presented with infantile spasms and progressed to Lennox-Gastaut syndrome revealed compound heterozygous variants in THAP12 , leading to a reduction in protein abundance, consistent with a loss-of-function mechanism. To confirm this mechanism in vivo , we generated mouse models carrying either of the two patient-specific alleles. Both homozygous and compound heterozygous animals exhibited embryonic lethality, confirming the essential and dosage-sensitive role of Thap12 during early development. Zebrafish loss-of-function models recapitulated major aspects of the human phenotype, including microcephaly, brain hypoplasia, abnormal neuronal activity, and increased seizure sensitivity. Transcriptomic profiling of larval zebrafish brains revealed dysregulation of cell cycle and apoptotic pathways, in line with increased cell death and reduced proliferation observed in mutant embryos. Notably, overexpression of wild-type human THAP12 mRNA rescued these in vivo phenotypes, while the patient-derived variants allele failed to do so. Altogether, our findings demonstrate that THAP12 is essential for early brain development and neuronal survival, and that biallelic loss-of-function variants in this gene underlie a previously unrecognized etiology of autosomal recessive DEE. These results provide a mechanistic framework linking, for the first time, THAP12 dysfunction to neurodevelopmental pathology and open new avenues for diagnosis in undiagnosed DEE cases.

19 September 2025 in medRxiv
Verified
Preprint
Open access
PDF file
JSJustin Simo
Justin Simo
AJAlexandre Janer
Alexandre Janer
HAHana Antonicka
Hana Antonicka
GMGabrielle Macaron
Gabrielle Macaron
AMandre megarbane
andre megarbane
RPRoberta La Piana
Roberta La Piana
Importance: Cellular mechanisms underlying mitochondrial dysfunction, a hallmark feature of many neurodegenerative conditions, remain incompletely understood, and their true diversity is unknown. Objective: To identify and functionally validate novel genetic variants causative of Leigh syndrome. Design: We performed whole genome sequencing (WGS) and first-degree relative genotyping on two unrelated adult subjects with brain MRI abnormalities evoking Leigh syndrome. Blue native polyacrylamide gel electrophoresis (BN-PAGE) and respiratory chain enzymatic activity assays were performed to screen for respiratory complex assembly and/or oxidative phosphorylation impairments. Cells obtained from patient dermal and muscular biopsies were immortalized and later genetically corrected to evaluate cellular response to metabolic stress. Setting: Subjects were recruited from The Neuro (McGill University), Rizk Hospital (Lebanese American University), and Centre Hospitalier Universitaire Sainte-Justine (University of Montreal). Research connections were established through the White Matter Rounds Network and GeneMatcher. Participants: Four subjects representing three families with undiagnosed Leigh syndrome (age range 10-40 years) were ultimately recruited. Main outcome(s) and Measure(s): DNA sequencing uncovered a new autosomal recessive Leigh syndrome-associated gene that was functionally validated. Results: Bi-allelic pathogenic variants in AMPD2 were detected in all subjects. BN-PAGE of patient skeletal muscle mitochondria captured an isolated complex V assembly defect in the context of heavy mTOR activation, while the accompanying enzymological assays reported decreased activities of complexes I and IV. Opposite to controls, patient-derived cell lines and muscle lacked AMPD2 protein, attributing null status to the variants detected. During metabolic challenge, only mutant cells suffered from mitochondrial hyperfusion and high-order cytosolic IMPDH2 oligomerization, implying simultaneous ATP accumulation and GTP deficiency. However, under these conditions, both complex V assembly and mTOR status in mutant cells and myotubes remained unchanged relative to the corrected lines. All mutant phenotypes observed collectively reverted upon exogenous introduction of wild-type AMPD2. Conclusions and Relevance: The recognition of AMPD2 -related Leigh syndrome ( AMPD2 -LS) as a novel entity provides strong evidence for classifying AMPD2 deficiency as a mitochondrial disease. Our data suggest that respiratory capacity is significantly modulated by AMPD2, a cytosolic enzyme selectively regulating complex V assembly through an elusive process. Key points: Question: Do AMPD2 mutations cause mitochondrial disease? Findings: In this case series, we found that four subjects from three families with molecularly unexplained Leigh syndrome carried bi-allelic, loss-of-function variants in AMPD2 , a gene not previously linked to mitochondrial disease. Biochemical analyses uncovered an isolated complex V assembly defect, providing diagnostic confirmation of a new entity: AMPD2 -related Leigh syndrome ( AMPD2 -LS). Meaning: The cytosolic purine cycle is a primordial determinant of oxidative phosphorylation and mitochondrial health.